Список литературы

1. Clark W. H., Jr., Elder D. E., Guerry D. t., Epstein M. N., Greene M. H., Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma//Hum Pathol. - 1984. - T. 15, N 12. - C. 1147 - 65.

2. Plonka P. M., Passeron T., Brenner M., Tobin D. J., Shibahara S., Thomas A., Slominski A., Kadekaro A. L., Hershkovitz D., Peters E., Nordlund J. J., Abdel-Malek Z., Takeda K., Paus R., Ortonne J. P., Hearing V. J., Schallreuter K. U. What are melanocytes really doing all day long...?//Exp Dermatol. - 2009. - T. 18, N 9. - C. 799 - 819.

3. Fitzpatrick T. B. The validity and practicality of sun-reactive skin types I through VI//Arch Dermatol. - 1988. - T. 124, N 6. - C. 869 - 71.

4. Pappo A. S. Melanoma in children and adolescents//Eur J Cancer. - 2003. - T. 39, N 18. - C. 2651 - 61.

5. Cordoro K. M., Gupta D., Frieden I. J., McCalmont T., Kashani-Sabet M. Pediatric melanoma: results of a large cohort study and proposal for modified ABCD detection criteria for children//J Am Acad Dermatol. - 2013. - T. 68, N 6. - C. 913 - 25.

6. Дорошенко М.Б., Утяшев И.А., Демидов Л.В., Алиев М.Д. Клинические и биологические особенности гигантских врожденных невусов у детей//Педиатрия. - 2016. - T. 95, N 4. - C. 50 - 56.

7. Austin M. T., Xing Y., Hayes-Jordan A. A., Lally K. P., Cormier J. N. Melanoma incidence rises for children and adolescents: an epidemiologic review of pediatric melanoma in the United States//J Pediatr Surg. - 2013. - T. 48, N 11. - C. 2207 - 13.

8. Lotze T. M., Dallal R. M., Kirkwood J. M., Flickinger J. C. Cutaneous Melanoma//Cancer: Principles and Practice of Oncology 6th edition/Devita V. T. и др. Lippincott Williams & Wilkins.

9. Youl P., Aitken J., Hayward N., Hogg D., Liu L., Lassam N., Martin N., Green A. Melanoma in adolescents: a case-control study of risk factors in Queensland, Australia//Int J Cancer. - 2002. - T. 98, N 1. - C. 92 - 8.

10. Whiteman D. C., Valery P., McWhirter W., Green A. C. Risk factors for childhood melanoma in Queensland, Australia//Int J Cancer. - 1997. - T. 70, N 1. - C. 26 - 31.

11. Merkel E. A., Mohan L. S., Shi K., Panah E., Zhang B., Gerami P. Paediatric melanoma: clinical update, genetic basis, and advances in diagnosis//Lancet Child Adolesc Health. - 2019. - T. 3, N 9. - C. 646 - 654.

12. Pappo A. S. Pediatric melanoma: the whole (genome) story//Am Soc Clin Oncol Educ Book. - 2014.10.14694/EdBook_AM.2014.34.e432. - C. e432 - 5.

13. Krengel S., Scope A., Dusza S. W., Vonthein R., Marghoob A. A. New recommendations for the categorization of cutaneous features of congenital melanocytic nevi//J Am Acad Dermatol. - 2013. - T. 68, N 3. - C. 441 - 51.

14. Anna B., Blazej Z., Jacqueline G., Andrew C. J., Jeffrey R., Andrzej S. Mechanism of UV-related carcinogenesis and its contribution to nevi/melanoma//Expert Rev Dermatol. - 2007. - T. 2, N 4. - C. 451 - 469.

15. Barr R. D., Ries L. A., Lewis D. R., Harlan L. C., Keegan T. H., Pollock B. H., Bleyer W. A., Adolescent U. S. N. C. I. S. o., Young Adult Oncology Epidemiology Working G. Incidence and incidence trends of the most frequent cancers in adolescent and young adult Americans, including "nonmalignant/noninvasive" tumors//Cancer. - 2016. - T. 122, N 7. - C. 1000 - 8.

16. Group U. S. C. S. W. United States Cancer Statistics: 1999 - 2013 Incidence and Mortality Web-based Report.//Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute - 2016 (дата обращения: August 1, 2016).

17. Lange J. R., Palis B. E., Chang D. C., Soong S. J., Balch C. M. Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base//J Clin Oncol. - 2007. - T. 25, N 11. - C. 1363 - 8.

18. Strouse J. J., Fears T. R., Tucker M. A., Wayne A. S. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database//J Clin Oncol. - 2005. - T. 23, N 21. - C. 4735 - 41.

19. Siegel D. A., King J., Tai E., Buchanan N., Ajani U. A., Li J. Cancer incidence rates and trends among children and adolescents in the United States, 2001 - 2009//Pediatrics. - 2014. - T. 134, N 4. - C. e945 - 55.

20. Campbell L. B., Kreicher K. L., Gittleman H. R., Strodtbeck K., Barnholtz-Sloan J., Bordeaux J. S. Melanoma Incidence in Children and Adolescents: Decreasing Trends in the United States//J Pediatr. - 2015. - T. 166, N 6. - C. 1505 - 13.

21. Noone A. M., Howlader N., Krapcho M., Miller D., Brest A., Yu M., Ruhl J., Tatalovich Z., Mariotto A., Lewis D. R., Chen H. S., Feuer E. J., Cronin K. A. SEER Cancer Statistics Review, 1975 - 2015//Bethesda, MD. - 2018.

22. Злокачественные новообразования в России в 2017 году (заболеваемость и смертность)/.- М.: МНИОИ им. П.А. Герцена - филиал ФГБУ "НМИЦ радиологии" Минздрава России, 2018.

23. Состояние онкологической помощи населению России в 2018 году/.- М.: МНИОИ им. П.А. Герцена - филиал ФГБУ "НМИЦ радиологии" Минздрава России, 2019.

24. International Statistical Classification of Diseases and Related Health Problems 10th Revision. - 2016. - URL: http://apps.who.int/classifications/icd10/browse/2016/en (дата обращения: 08JAN2017.2017).

25. Состояние онкологическои помощи населению России в 2017 году/. - М.: МНИОИ им. П.А. Герцена - филиал ФГБУ "НМИЦ радиологии" Минздрава России, 2018.

26. Gershenwald J., Scolyer R., Hess K., al. e. Melanoma of the skin//AJCC Cancer Staging Manual 8th ed/Amin M. и др. - New York: Springer International Publishing, 2017. - C. 563 - 585.

27. Barr R. G. Foreword to the Second Set of WFUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography//Ultrasound Med Biol. - 2017. - T. 43, N 1. - C. 1 - 3.

28. Синельников И.Е., Барышников К.А., Демидов Л.В. КЛИНИЧЕСКАЯ ДИАГНОСТИКА МЕЛАНОМЫ КОЖИ//Вестник ФГБУ "РОНЦ им. Н.Н. Блохина". - 2017. - T. 28, N 1 - 2. - C. 68 - 73.

29. Grob J. J., Bonerandi J. J. The "ugly duckling" sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening//Arch Dermatol. - 1998. - T. 134, N 1. - C. 103 - 4.

30. Garbe C., Peris K., Hauschild A., Saiag P., Middleton M., Bastholt L., Grob J. J., Malvehy J., Newton-Bishop J., Stratigos A. J., Pehamberger H., Eggermont A. M., European Dermatology F., European Association of D.-O., European Organisation for R., Treatment of C. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016//Eur J Cancer. - 2016. - T. 63. - C. 201 - 17.

31. Ferrari A., Bisogno G., Cecchetto G., Santinami M., Maurichi A., Bono A., Vajna De Pava M., Pierani P., Bertolini P., Rossi C. R., De Salvo G. L. Cutaneous melanoma in children and adolescents: the Italian rare tumors in pediatric age project experience//J Pediatr. - 2014. - T. 164, N 2. - C. 376 - 82 e1 - 2.

32. Rajput A., Faizi S. A., Nir I., Morris K. T., Fahy B., Russell J., Wiggins C. Pediatric melanoma in New Mexico American Indians, Hispanics, and non-Hispanic whites, 1981 - 2009//Am J Surg. - 2014. - T. 207, N 3. - C. 412 - 6; discussion 416.

33. Mitkov M., Chrest M., Diehl N. N., Heckman M. G., Tollefson M., Jambusaria-Pahlajani A. Pediatric melanomas often mimic benign skin lesions: A retrospective study//J Am Acad Dermatol. - 2016. - T. 75, N 4. - C. 706 - 711 e4.

34. Silverberg N., McCuaig C. Melanoma in Childhood: Changing Our Mind-set//Cutis. - 2013. - T. 92. - C. 217 - 8.

35. Berk D. R., LaBuz E., Dadras S. S., Johnson D. L., Swetter S. M. Melanoma and melanocytic tumors of uncertain malignant potential in children, adolescents and young adults--the Stanford experience 1995 - 2008//Pediatr Dermatol. - 2010. - T. 27, N 3. - C. 244 - 54.

36. Massi D., Tomasini C., Senetta R., Paglierani M., Salvianti F., Errico M. E., Donofrio V., Collini P., Tragni G., Sementa A. R., Rongioletti F., Boldrini R., Ferrari A., Gambini C., Montesco M. C. Atypical Spitz tumors in patients younger than 18 years//J Am Acad Dermatol. - 2015. - T. 72, N 1. - C. 37 - 46.

37. Zhao G., Lee K. C., Peacock S., Reisch L. M., Knezevich S. R., Elder D. E., Piepkorn M. W., Elmore J. G., Barnhill R. L. The utilization of spitz-related nomenclature in the histological interpretation of cutaneous melanocytic lesions by practicing pathologists: results from the M-Path study//J Cutan Pathol. - 2017. - T. 44, N 1. - C. 5 - 14.

38. Tlougan B. E., Orlow S. J., Schaffer J. V. Spitz nevi: beliefs, behaviors, and experiences of pediatric dermatologists//JAMA Dermatol. - 2013. - T. 149, N 3. - C. 283 - 91.

39. Marghoob A. A. Practice gaps. Underuse of dermoscopy in assessing Spitz nevi in children: comment on "Spitz nevi: beliefs, behaviors, and experiences of pediatric dermatologists"//JAMA Dermatol. - 2013. - T. 149, N 3. - C. 291 - 2.

40. Chaithirayanon S., Chunharas A. A survey of birthmarks and cutaneous skin lesions in newborns//J Med Assoc Thai. - 2013. - T. 96 Suppl 1. - C. S49 - 53.

41. Haveri F. T., Inamadar A. C. A cross-sectional prospective study of cutaneous lesions in newborn//ISRN Dermatol. - 2014. - T. 2014. - C. 360590.

42. Wong J. R., Harris J. K., Rodriguez-Galindo C., Johnson K. J. Incidence of childhood and adolescent melanoma in the United States: 1973 - 2009//Pediatrics. - 2013. - T. 131, N 5. - C. 846 - 54.

43. Nikfarjam J., Chambers E. Congenital Melanocytic Nevi and the Risk of Malignant Melanoma: Establishing a Guideline for Primary-Care Physicians//Einstein Journal of Biology and Medicine. - 2016. - T. 27. - C. 59.

44. Yun S. J., Kwon O. S., Han J. H., Kweon S. S., Lee M. W., Lee D. Y., Kim M. B., Kim Y. C., Yoon T. Y., Chung K. Y., Kim I. H., Kim K. H., Suh K. S., Lee S. J., Seo Y. J., Kim K. H., Park H. J., Roh M. R., Ahn K. J., Yoon T. J., Kim M. H., Li K. S., Park J. S., Shin B. S., Ko J. Y., Ahn H. H., Kim H. J., Park S. D., Jang S. J., Won Y. H. Clinical characteristics and risk of melanoma development from giant congenital melanocytic naevi in Korea: a nationwide retrospective study//Br J Dermatol. - 2012. - T. 166, N 1. - C. 115 - 23.

45. Stefanaki C., Soura E., Plaka M., Chasapi V., Polydorou D., Antoniou C., Stratigos A. A case series of paediatric and adolescent melanoma//Eur J Dermatol. - 2018. - T. 28, N 1. - C. 120 - 122.

46. Stefanaki C., Chardalias L., Soura E., Katsarou A., Stratigos A. Paediatric melanoma//J Eur Acad Dermatol Venereol. - 2017. - T. 31, N 10. - C. 1604 - 1615.

47. Livestro D. P., Kaine E. M., Michaelson J. S., Mihm M. C., Haluska F. G., Muzikansky A., Sober A. J., Tanabe K. K. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis//Cancer. - 2007. - T. 110, N 3. - C. 614 - 24.

48. Tricoli J. V., Blair D. G., Anders C. K., Bleyer W. A., Boardman L. A., Khan J., Kummar S., Hayes-Lattin B., Hunger S. P., Merchant M., Seibel N. L., Thurin M., Willman C. L. Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma//Cancer. - 2016. - T. 122, N 7. - C. 1017 - 28.

49. Abbasi N. R., Shaw H. M., Rigel D. S., Friedman R. J., McCarthy W. H., Osman I., Kopf A. W., Polsky D. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria//JAMA. - 2004. - T. 292, N 22. - C. 2771 - 6.

50. Nino M., Brunetti B., Delfino S., Brunetti B., Panariello L., Russo D. Spitz nevus: follow-up study of 8 cases of childhood starburst type and proposal for management//Dermatology. - 2009. - T. 218, N 1. - C. 48 - 51.

51. Pizzichetta M. A., Talamini R., Marghoob A. A., Soyer H. P., Argenziano G., Bono R., Corradin M. T., De Giorgi V., Gonzalez M. A., Kolm I., Kopf A. W., Malvehy J., Nami N., Oliviero M., Pellacani G., Puig S., Rabinovitz H., Rubegni P., Seidenari S., Stanganelli I., Veronesi A., Zalaudek I., Zampieri P., Menzies S. W. Negative pigment network: an additional dermoscopic feature for the diagnosis of melanoma//J Am Acad Dermatol. - 2013. - T. 68, N 4. - C. 552 - 559.

52. Zalaudek I., Kittler H., Hofmann-Wellenhof R., Kreusch J., Longo C., Malvehy J., Puig S., Moscarella E., Piana S., Massone C., Cota C., Ferrara G., Fleischer M., Argenziano G. "White" network in Spitz nevi and early melanomas lacking significant pigmentation//J Am Acad Dermatol. - 2013. - T. 69, N 1. - C. 56 - 60.

53. Adler N. R., Kelly J. W., Guitera P., Menzies S. W., Chamberlain A. J., Fishburn P., Button-Sloan A. E., Heal C., Soyer H. P., Thompson J. F. Methods of melanoma detection and of skin monitoring for individuals at high risk of melanoma: new Australian clinical practice//Med J Aust. - 2019. - T. 210, N 1. - C. 41 - 47.

54. Giavedoni P., Ririe M., Carrera C., Puig S., Malvehy J. Familial Melanoma Associated with Li-Fraumeni Syndrome and Atypical Mole Syndrome: Total-body Digital Photography, Dermoscopy and Confocal Microscopy//Acta Derm Venereol. - 2017. - T. 97, N 6. - C. 720 - 723.

55. Kittler H., Guitera P., Riedl E., Avramidis M., Teban L., Fiebiger M., Weger R. A., Dawid M., Menzies S. Identification of clinically featureless incipient melanoma using sequential dermoscopy imaging//Arch Dermatol. - 2006. - T. 142, N 9. - C. 1113 - 9.

56. Rinner C., Tschandl P., Sinz C., Kittler H. Long-term evaluation of the efficacy of digital dermatoscopy monitoring at a tertiary referral center//J Dtsch Dermatol Ges. - 2017. - T. 15, N 5. - C. 517 - 522.

57. Robinson J. K., Nickoloff B. J. Digital epiluminescence microscopy monitoring of high-risk patients//Arch Dermatol. - 2004. - T. 140, N 1. - C. 49 - 56.

58. Tschandl P., Hofmann L., Fink C., Kittler H., Haenssle H. A. Melanomas vs. nevi in high-risk patients under long-term monitoring with digital dermatoscopy: do melanomas and nevi already differ at baseline?//J Eur Acad Dermatol Venereol. - 2017. - T. 31, N 6. - C. 972 - 977.

59. Watts C. G., Wortley S., Norris S., Menzies S. W., Guitera P., Askie L., Mann G. J., Morton R. L., Cust A. E. A National Budget Impact Analysis of a Specialised Surveillance Programme for Individuals at Very High Risk of Melanoma in Australia//Appl Health Econ Health Policy. - 2018. - T. 16, N 2. - C. 235 - 242.

60. Argenziano G., Agozzino M., Bonifazi E., Broganelli P., Brunetti B., Ferrara G., Fulgione E., Garrone A., Zalaudek I. Natural evolution of Spitz nevi//Dermatology. - 2011. - T. 222, N 3. - C. 256 - 60.

61. Berk-Krauss J., Polsky D., Stein J. A. Mole Mapping for Management of Pigmented Skin Lesions//Dermatol Clin. - 2017. - T. 35, N 4. - C. 439 - 445.

62. Truong A., Strazzulla L., March J., Boucher K. M., Nelson K. C., Kim C. C., Grossman D. Reduction in nevus biopsies in patients monitored by total body photography//J Am Acad Dermatol. - 2016. - T. 75, N 1. - C. 135 - 143 e5.

63. Inskip M., Magee J., Weedon D., Rosendahl C. When algorithms falter: a case report of a very small melanoma excised due to the dermatoscopic "ugly duckling" sign//Dermatol Pract Concept. - 2013. - T. 3, N 2. - C. 59 - 62.

64. Akay B. N., Okcu Heper A., Clark S., Erdem C., Rosendahl C. O., Kittler H. Dermatoscopy of a melanoma less than one millimeter in diameter//Int J Dermatol. - 2017. - T. 56, N 12. - C. 1498 - 1499.

65. Uffman J. C., Tumin D., Raman V., Thung A., Adler B., Tobias J. D. MRI Utilization and the Associated Use of Sedation and Anesthesia in a Pediatric ACO//J Am Coll Radiol. - 2017. - T. 14, N 7. - C. 924 - 930.

66. Schlatter J., Kabiche S., Sellier N., Fontan J. E. Oral pentobarbital suspension for children sedation during MR imaging//Ann Pharm Fr. - 2018. - T. 76, N 4. - C. 286 - 290.

67. Nagoshi M., Reddy S., Bell M., Cresencia A., Margolis R., Wetzel R., Ross P. Low-dose dexmedetomidine as an adjuvant to propofol infusion for children in MRI: A double-cohort study//Paediatr Anaesth. - 2018. - T. 28, N 7. - C. 639 - 646.

68. McGuirt D. Alternatives to Sedation and General Anesthesia in Pediatric Magnetic Resonance Imaging: A Literature Review//Radiol Technol. - 2016. - T. 88, N 1. - C. 18 - 26.

69. Greene D. J., Koller J. M., Hampton J. M., Wesevich V., Van A. N., Nguyen A. L., Hoyt C. R., McIntyre L., Earl E. A., Klein R. L., Shimony J. S., Petersen S. E., Schlaggar B. L., Fair D. A., Dosenbach N. U. F. Behavioral interventions for reducing head motion during MRI scans in children//Neuroimage. - 2018. - T. 171. - C. 234 - 245.

70. Bharti B., Malhi P., Khandelwal N. MRI Customized Play Therapy in Children Reduces the Need for Sedation--A Randomized Controlled Trial//Indian J Pediatr. - 2016. - T. 83, N 3. - C. 209 - 13.

71. Moscarella E., Piccolo V., Argenziano G., Lallas A., Longo C., Castagnetti F., Pizzigoni S., Zalaudek I. Problematic lesions in children//Dermatol Clin. - 2013. - T. 31, N 4. - C. 535 - 47, vii.

72. Lallas A., Apalla Z., Ioannides D., Lazaridou E., Kyrgidis A., Broganelli P., Alfano R., Zalaudek I., Argenziano G., International Dermoscopy S. Update on dermoscopy of Spitz/Reed naevi and management guidelines by the International Dermoscopy Society//Br J Dermatol. - 2017. - T. 177, N 3. - C. 645 - 655.

73. Pflugfelder A., Weide B., Eigentler T. K., Forschner A., Leiter U., Held L., Meier F., Garbe C. Incisional biopsy and melanoma prognosis: Facts and controversies//Clin Dermatol. - 2010. - T. 28, N 3. - C. 316 - 8.

74. Rork J. F., Hawryluk E. B., Liang M. G. Literature Update on Melanocytic Nevi and Pigmented Lesions in the Pediatric Population//Current Dermatology Reports. - 2012. - T. 1, N 4. - C. 195 - 202.

75. Shah J., Feintisch A. M., Granick M. S. Congenital Melanocytic Nevi//Eplasty. - 2016. - T. 16. - C. ic4.

76. Tannous Z. S., Mihm M. C., Jr., Sober A. J., Duncan L. M. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management//J Am Acad Dermatol. - 2005. - T. 52, N 2. - C. 197 - 203.

77. Price H. N. Congenital melanocytic nevi: update in genetics and management//Curr Opin Pediatr. - 2016. - T. 28, N 4. - C. 476 - 82.

78. Navid F., Furman W. L., Fleming M., Rao B. N., Kovach S., Billups C. A., Cain A. M., Amonette R., Jenkins J. J., Pappo A. S. The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma//Cancer. - 2005. - T. 103, N 4. - C. 780 - 7.

79. Navid F., Herzog C. E., Sandoval J., Daryani V. M., Stewart C. F., Gattuso J., Mandrell B., Phipps S., Chemaitilly W., Sykes A., Davidoff A. M., Shulkin B. L., Bahrami A., Furman W. L., Mao S., Wu J., Schiff D., Rao B., Pappo A. Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk Melanoma//Pediatr Blood Cancer. - 2016. - T. 63, N 7. - C. 1207 - 13.

80. Kirkwood J. M., Manola J., Ibrahim J., Sondak V., Ernstoff M. S., Rao U., Eastern Cooperative Oncology G. A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma//Clin Cancer Res. - 2004. - T. 10, N 5. - C. 1670 - 7.

81. Kirkwood J. M., Ibrahim J. G., Sondak V. K., Richards J., Flaherty L. E., Ernstoff M. S., Smith T. J., Rao U., Steele M., Blum R. H. High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190//J Clin Oncol. - 2000. - T. 18, N 12. - C. 2444 - 58.

82. Kirkwood J. M., Ibrahim J. G., Sosman J. A., Sondak V. K., Agarwala S. S., Ernstoff M. S., Rao U. High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801//J Clin Oncol. - 2001. - T. 19, N 9. - C. 2370 - 80.

83. Marjanska A., Galazka P., Marjanski M., Wysocki M., Styczynski J. Efficacy and Toxicity of Pembrolizumab in Pediatric Metastatic Recurrent Melanoma//Anticancer Res. - 2019. - T. 39, N 7. - C. 3945 - 3947.

84. Geoerger B., Bergeron C., Gore L., Sender L., Dunkel I. J., Herzog C., Brochez L., Cruz O., Nysom K., Berghorn E., Simsek B., Shen J., Pappo A. Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma//Eur J Cancer. - 2017. - T. 86. - C. 358 - 363.

85. Geoerger B., Kang H. J., Yalon-Oren M., Marshall L. V., Vezina C., Pappo A., Laetsch T. W., Petrilli A. S., Ebinger M., Toporski J., Glade-Bender J., Nicholls W., Fox E., DuBois S. G., Macy M. E., Cohn S. L., Pathiraja K., Diede S. J., Ebbinghaus S., Pinto N. Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1 - 2 trial//Lancet Oncol. - 2020. - T. 21, N 1. - C. 121 - 133.

86. Merchant M. S., Wright M., Baird K., Wexler L. H., Rodriguez-Galindo C., Bernstein D., Delbrook C., Lodish M., Bishop R., Wolchok J. D., Streicher H., Mackall C. L. Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors//Clin Cancer Res. - 2016. - T. 22, N 6. - C. 1364 - 70.

87. Weyand A. C., Mody R. J., Rabah R. M., Opipari V. P. PD-1 inhibition in congenital pigment synthesizing metastatic melanoma//Pediatr Blood Cancer. - 2018. - T. 65, N 1.

88. Chisholm J. C., Suvada J., Dunkel I. J., Casanova M., Zhang W., Ritchie N., Choi Y., Park J., Das Thakur M., Simko S., Wan Rachel Tam N., Ferrari A. BRIM-P: A phase I, open-label, multicenter, dose-escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation-positive melanoma//Pediatr Blood Cancer. - 2018. - T. 65, N 5. - C. e26947.

89. Buyukkapu Bay S., Kebudi R., Zulfikar B. Cutaneous adverse event associated with vemurafenib in a 3-year-old pediatric patient with BRAF mutation-positive metastatic melanoma and factor X deficiency//Melanoma Res. - 2019. - T. 29, N 1. - C. 99 - 101.

90. Bay S. B., Gorgun O., Kebudi R. Children with malignant melanoma: a single center experience from Turkey//Turk Pediatri Ars. - 2020. - T. 55, N 1. - C. 39 - 45.

91. Boddie A. W., Jr., Cangir A. Adjuvant and neoadjuvant chemotherapy with dacarbazine in high-risk childhood melanoma//Cancer. - 1987. - T. 60, N 8. - C. 1720 - 3.

92. Toll S. A., Tran H. N., Cotter J., Judkins A. R., Tamrazi B., Biegel J. A., Dhall G., Robison N. J., Waters K., Patel P., Cooper R., Margol A. S. Sustained response of three pediatric BRAF(V600E) mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy//Oncotarget. - 2019. - T. 10, N 4. - C. 551 - 557.

93. Kieran M. W., Geoerger B., Dunkel I. J., Broniscer A., Hargrave D., Hingorani P., Aerts I., Bertozzi A. I., Cohen K. J., Hummel T. R., Shen V., Bouffet E., Pratilas C. A., Pearson A. D. J., Tseng L., Nebot N., Green S., Russo M. W., Whitlock J. A. A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation-Positive Solid Tumors//Clin Cancer Res. - 2019. - T. 25, N 24. - C. 7294 - 7302.

94. August D. A., Huhmann M. B., American Society for P., Enteral Nutrition Board of D. A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation//JPEN J Parenter Enteral Nutr. - 2009. - T. 33, N 5. - C. 472 - 500.

95. Isenring E., Elia M. Which screening method is appropriate for older cancer patients at risk for malnutrition?//Nutrition. - 2015. - T. 31, N 4. - C. 594 - 7.

96. Martin L., Senesse P., Gioulbasanis I., Antoun S., Bozzetti F., Deans C., Strasser F., Thoresen L., Jagoe R. T., Chasen M., Lundholm K., Bosaeus I., Fearon K. H., Baracos V. E. Diagnostic criteria for the classification of cancer-associated weight loss//J Clin Oncol. - 2015. - T. 33, N 1. - C. 90 - 9.

97. Manary M. J., Sandige H. L. Management of acute moderate and severe childhood malnutrition//BMJ. - 2008. - T. 337. - C. a2180.

98. Van den Broeck J., Eeckels R., Massa G. Validity of single-weight measurements to predict current malnutrition and mortality in children//J Nutr. - 1996. - T. 126, N 1. - C. 113 - 20.

99. Meijers J. M., Tan F., Schols J. M., Halfens R. J. Nutritional care; do process and structure indicators influence malnutrition prevalence over time?//Clin Nutr. - 2014. - T. 33, N 3. - C. 459 - 65.

100. Muscaritoli M., Anker S. D., Argiles J., Aversa Z., Bauer J. M., Biolo G., Boirie Y., Bosaeus I., Cederholm T., Costelli P., Fearon K. C., Laviano A., Maggio M., Rossi Fanelli F., Schneider S. M., Schols A., Sieber C. C. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics"//Clin Nutr. - 2010. - T. 29, N 2. - C. 154 - 9.

101. Kondrup J., Allison S. P., Elia M., Vellas B., Plauth M., Educational, Clinical Practice Committee E. S. o. P., Enteral N. ESPEN guidelines for nutrition screening 2002//Clin Nutr. - 2003. - T. 22, N 4. - C. 415 - 21.

102. Arends J., Bachmann P., Baracos V., Barthelemy N., Bertz H., Bozzetti F., Fearon K., Hutterer E., Isenring E., Kaasa S., Krznaric Z., Laird B., Larsson M., Laviano A., Muhlebach S., Muscaritoli M., Oldervoll L., Ravasco P., Solheim T., Strasser F., de van der Schueren M., Preiser J. C. ESPEN guidelines on nutrition in cancer patients//Clin Nutr. - 2017. - T. 36, N 1. - C. 11 - 48.

103. Joosten K. F., Kerklaan D., Verbruggen S. C. Nutritional support and the role of the stress response in critically ill children//Curr Opin Clin Nutr Metab Care. - 2016. - T. 19, N 3. - C. 226 - 33.

104. Koletzko B., Goulet O., Hunt J., Krohn K., Shamir R., Parenteral Nutrition Guidelines Working G., European Society for Clinical N., Metabolism, European Society of Paediatric Gastroenterology H., Nutrition, European Society of Paediatric R. 1. Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR)//J Pediatr Gastroenterol Nutr. - 2005. - T. 41 Suppl 2. - C. S1 - 87.

105. Tanner L., Keppner K., Lesmeister D., Lyons K., Rock K., Sparrow J. Cancer Rehabilitation in the Pediatric and Adolescent/Young Adult Population//Semin Oncol Nurs. - 2020. - T. 36, N 1. - C. 150984.

106. Siegel G. W., Biermann J. S., Chugh R., Jacobson J. A., Lucas D., Feng M., Chang A. C., Smith S. R., Wong S. L., Hasen J. The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework//J Multidiscip Healthc. - 2015. - T. 8. - C. 109 - 15.

107. Maeda T., Sato K., Minami H., Taguchi H., Yoshikawa K. PCR-RFLP analysis as an aid to genetic counseling of families of Japanese patients with group A xeroderma pigmentosum//J Invest Dermatol. - 1997. - T. 109, N 3. - C. 306 - 9.

108. Tomatir A. G., Sorkun H. C., Demirhan H., Akdag B. Genetics and genetic counseling: practices and opinions of primary care physicians in Turkey//Genet Med. - 2007. - T. 9, N 2. - C. 130 - 5.

109. Bloom A. D. Genetic counseling in pediatric dermatology//Mod Probl Paediatr. - 1975. - T. 17. - C. 1 - 5.

110. Soura E., Eliades P. J., Shannon K., Stratigos A. J., Tsao H. Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome//J Am Acad Dermatol. - 2016. - T. 74, N 3. - C. 395 - 407; quiz 408 - 10.

111. Borroni R. G., Manganoni A. M., Grassi S., Grasso M., Diegoli M., Giorgianni C., Favalli V., Pavoni L., Cespa M., Arbustini E. Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy//Melanoma Res. - 2017. - T. 27, N 2. - C. 97 - 103.

112. Belysheva T. S., Vishnevskaya Y. V., Nasedkina T. V., Emelyanova M. A., Abramov I. S., Orlova K. V., Lubchenko L. N., Utyashev I. A., Doroshenko M. B., Demidov L. V., Aliev M. D. Melanoma arising in a Giant congenital melanocytic nevus: two case reports//Diagn Pathol. - 2019. - T. 14, N 1. - C. 21.

113. Kinsler V. A., Thomas A. C., Ishida M., Bulstrode N. W., Loughlin S., Hing S., Chalker J., McKenzie K., Abu-Amero S., Slater O., Chanudet E., Palmer R., Morrogh D., Stanier P., Healy E., Sebire N. J., Moore G. E. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS//J Invest Dermatol. - 2013. - T. 133, N 9. - C. 2229 - 36.

114. The TNM classification of malignant tumours 8th edition/. -: Wiley-Blackwell, 2009.

115. Schneider J. The teaspoon rule of applying sunscreen//Arch Dermatol. - 2002. - T. 138, N 6. - C. 838 - 9.

116. Oken M. M., Creech R. H., Tormey D. C., Horton J., Davis T. E., McFadden E. T., Carbone P. P. Toxicity and response criteria of the Eastern Cooperative Oncology Group//Am J Clin Oncol. - 1982. - T. 5, N 6. - C. 649 - 55.

117. Karnofsky D. A., Burchenal J. H. The clinical evaluation of chemotherapeutic agents in cancer//Evaluation of chemotherapeutic agents/MacLeod C. - New York: Columbia University Press, 1949. - C. 191 - 205.

118. Методические рекомендации по применению критериев ответа солидных опухолей на химиотерапевтическое лечение (RECIST 1.1). Методические рекомендации N 46/. -, 2018. - 15 с.